Oramed Pharmaceuticals COO Joshua Hexter receives $578K in 2013
Oramed Pharmaceuticals reports 2013 executive compensation
By ExecPay News
Published: June 17, 2014
Oramed Pharmaceuticals reported fiscal year 2013 executive compensation information on June 17, 2014.
In 2013, four executives at Oramed Pharmaceuticals received on average a compensation package of $294K, a 36% increase compared to previous year.
Average pay of disclosed executives at Oramed Pharmaceuticals
Joshua Hexter, Chief Operating Officer, received $578K in total. 90% of Hexter's compensation, or $520K, was in option awards. Hexter also received $48K in salary and $10K in other compensation.
Nadav Kidron, Chief Executive Officer, received a compensation package of $272K, which increased by 2% compared to previous year. 67% of the compensation package, or $183K, was in salary.
Miriam Kidron, Chief Medical and Technology Officer and director, earned $200K in 2013, a 23% decrease compared to previous year.
Yifat Zommer, Chief Financial Officer, received $127K in 2013, which increases by 5% compared to 2012.
Oramed Pharmaceuticals' fiscal year ends on August 31.
Related executives
You may also like
Source: SEC filing on June 17, 2014.